Emgality Archives - PEPID Pulse

FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

by PEPID Newsroom | Jun 4, 2019 | Alerts

Emgality (gacanezumab-gnlm) solution has been FDA approved for treatment of episodic cluster headache in adults, the first of its kind. Emgality was approved in 2018 to prevent migraines in adults, and now has shown to reduce the frequency of cluster headache attaches...

FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

Recent Posts

Categories